glide/gcmIs Expressed and Required in the Scavenger Cell Lineage  by Vivancos, Roberto Bernardoni, Valérie & Giangrande, Angela
DEVELOPMENTAL BIOLOGY 191, 118±130 (1997)
ARTICLE NO. DB978702
glide/gcm Is Expressed and Required
in the Scavenger Cell Lineage
Roberto Bernardoni, ValeÂrie Vivancos,1 and Angela Giangrande2
Institut de GeÂneÂtique et Biologie MoleÂculaire et Cellulaire, IGBMC/CNRS/ULP,
BP 163 67404 Illkirch, c.u. de Strasbourg, France
Glial cell differentiation in Drosophila melanogaster requires the activity of glide/gcm (glial cell de®cient/glial cell
missing). The role of this gene is to direct the cell fate switch between neurons and glial cells by activating the glial
developmental program in multipotent precursor cells of the nervous system. In this paper, we show that glide/gcm is
also expressed and required in the lineage of hemocytes/macrophages, scavenger cells that phagocytose cells undergoing
programmed cell death. In addition, we show that, as for glial cells, glide/gcm plays an instructive role in hemocyte
differentiation. Interestingly, it has been shown that in the development of the ¯y adult nervous system the role of
scavenger cells is played by glial cells. These data and our ®ndings on the dual role of glide/gcm indicate that glial cells
and hemocytes/macrophages are functionally and molecularly related. q 1997 Academic Press
INTRODUCTION differentiation (Tepass et al., 1994). By late embryonic
stages most hemocytes develop into macrophages which
engulf cells undergoing apoptosis, a process that removesIn Drosophila melanogaster, glial cell differentiation re-
cells and reshapes tissues during normal development (Ab-quires a glial promoting factor represented by the glide/gcm
rams et al., 1993; Tepass et al., 1994; see White and Steller,product (glide stands for glial cells de®cient: Vincent et al.,
1995, for a review). Despite these features, due to the lack1996; gcm stands for glial cell missing: Jones et al., 1995;
of mutations speci®cally affecting this cell type, the rela-Hosoya et al., 1995; see also for reviews KlaÈmbt et al., 1996;
tionships existing between macrophages and cell death areGiangrande, 1996). In glide/gcm embryos, all but midline
poorly understood. Indeed, hemocyte differentiation pre-glial cells are absent due to their transformation into neu-
cedes cell death and does not depend on it: the number ofrons (see for reviews Pfrieger and Barres, 1995; Anderson,
macrophages does not change in mutants with increased1995; Giangrande, 1996). glide/gcm is a DNA binding pro-
cell death (Tepass et al., 1994). Conversely, it has beentein (Akiyama et al., 1996) that most likely regulates the
shown that in mutants lacking macrophages cell death oc-expression of genes such as reverse polarity (repo) (Camp-
curs as in wild type (Tepass et al., 1994).bell et al., 1994; Xiong et al., 1994; Halter et al., 1995),
In this paper we show that, well before its activation inprospero (pros) (Doe et al., 1991; Vaessin et al., 1991), and
the glial lineage, glide/gcm is expressed early and tran-pointed (pnt) (KlaÈmbt, 1993; Klaes et al., 1994) which exe-
siently during hemocyte/macrophage differentiation. Wecute the glial differentiation program.
have analyzed the role of glide/gcm in this lineage andInterestingly, we have observed that glide/gcm is also
shown that it participates in the differentiation of hemocyteexpressed in hemocyte presumptive territories. Embryonic
precursors. Moreover, we demonstrate that glide/gcm ex-hemocytes, which are migratory cells involved in phagocy-
pression is necessary and suf®cient to induce the hemocytetosis, represent the homologs of vertebrate scavenger cells
fate. The precise role of hemocytes in the execution of the(Abrams et al., 1993; Tepass et al., 1994; Franc et al., 1996).
cell death program can now be analyzed in detail usingIt is known that they originate from the procephalic meso-
glide/gcm. The identi®cation of the role of glide/gcm in thederm but little is known about the genes involved in their
hemocyte lineage also constitutes a starting point for the
de®nition of other genes participating in the same pathway.
Indeed, our results indicate that glide/gcm expression in1 Present address: Zoologische Institute, UniversitaÈt ZuÈ rich,
the hemocyte lineage depends on the activity of the serpentWinterhurerstr. 190, ZuÈ rich, Switzerland.
GATA transcription factor (JuÈ rgens et al., 1984; Abel et al.,2 To whom correspondence should be addressed. Fax: (33)388653201.
E-mail: angela@titus.u-strasbg.fr. 1993; Sam et al., 1996).
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MATERIALS AND METHODS RESULTS
Strains glide/gcm Is Expressed in the Hemocyte/
Macrophage LineageWild-type strain was Sevelen. glide/gcm mutants were crossed
to a blue second chromosome balancer in order to recognize homo-
Hemocytes are cells of mesodermal origin that dispersezygous mutant embryos. The blue balancer carried a twi-lacZ fu-
along migratory pathways in the embryo (Tepass et al.,sion that leads to bgal expression in mesoderm derivatives (Thisse
1994). The ®rst stage at which they can be identi®ed is lateet al., 1991). glide/gcmN7-4 is a lethal complementation group in
the 30B region (Lane and Kalderon, 1993), and glide/gcm34 and stage 10 in a subpopulation of cells located in the head of
glide/gcm26 (Vincent et al., 1996) were obtained in a P element the embryo (Tepass et al., 1994). During the ®rst wave of
mutagenesis on the enhancer trap line rA87. To determine the apoptosis normally occurring during midembryogenesis,
epistasy between glide/gcm and serpent, we used two overlapping some of them convert into macrophages that engulf and
de®ciencies, one that eliminates serpent, Df(3R)sbd105 pp bx sr1 degrade cells undergoing programmed cell death. Conver-
es/LVM and another that does not, Df(3R) sbd 45e/TM3, used as a
sion into cells with phagocytic activity continues through-positive control.
out development and by the end of embryogenesis mostThe hs-glide/gcm plasmid was constructed by inserting the full-
hemocytes have become macrophages.length glide/gcm cDNA (Verdeil and Giangrande, unpublished re-
glide/gcm (Hosoya et al., 1995; Jones et al., 1995; Vincentsults) as an EcoRI fragment into the pCasper-hs injection vector.
et al., 1996) has been identi®ed by P element mutagenesisThe UAS-glide/gcm plasmid was obtained by inserting the same
fragment into pCasper UAST (pUAST). Transgenic ¯ies were ob- on the glial-speci®c enhancer trap line rA87 (Giangrande et
tained by injecting the two plasmids into w1118 animals using ppD2- al., 1993; Klaes et al., 1994; Halter et al., 1995). Interest-
3 as helper plasmid. hs-glide/gcm embryos were collected for 2 hr ingly, we have observed that anti-bgal and anti-peroxidasin,
at 257C and then shifted at 337C for 75 minutes. Embryos were an antibody that speci®cally recognizes hemocytes (Nelson
subsequently returned at 257C for 6 hr and treated for immunohis- et al., 1994), colocalize in rA87 embryos, which strongly
tochemistry as described in Vincent et al. (1996). To obtain neu-
suggests that glide/gcm is expressed in all hemocytes (Fig.ronal glide/gcm expression, the UAS-glide/gcm transgenic line was
1). Colocalization has also been observed at early stages ofcrossed with elav-GAL4 (Luo et al., 1994).
hemocyte development, before the ®rst wave of apoptosis
and before the conversion of hemocytes into macrophages
(Fig. 1). This result eliminates the possibility that bgal is
RNA Analysis expressed in dying cells that have been engulfed by hemo-
cytes. Moreover, colocalization between peroxidasin andIn situ hybridizations were performed on embryos after over-
bgal has been observed throughout development and at nonight collection. In the case of glide/gcm embryos, in situ was
stage did nuclei expressing bgal reveal the features of apop-followed by Xgal labeling as described in Lehmann and Tautz (1994)
in order to recognize mutant embryos. Single-strand digoxigenin- totic nuclei.
labeled probes for in situ hybridization were obtained by PCR using We analyzed early embryonic stages in order to de®ne
oligonucleotides contained in the glide/gcm cDNA sequence (Ver- when glide/gcm is ®rst expressed in the hemocyte/macro-
deil and Giangrande, unpublished results). Sense probes were used phage lineage. We observed that bgal expression precedes
as a negative control. peroxidasin expression, which starts at stage 10, as well as
any sign of overt differentiation. In fact, bgal can be detected
at stage 8 in a sharply de®ned domain of the procephalic
Preparation of Antibodies, Western Blot Analysis, mesoderm, as con®rmed by its colocalization with twist, a
and Immunohistochemistry protein expressed in all mesoderm presumptive territories
(Thisse et al., 1988) (Fig. 2). As soon as peroxidasin starts
Antibodies were raised against a peptide contained in the amino- being expressed and until the end of embryogenesis, the
terminal region of the glide/gcm protein. Peptide was coupled with
bgal pro®le of expression faithfully reproduces that of per-ovalbumin, puri®ed, and injected into rabbits. Western blots were
oxidasin (Nelson et al., 1994; Tepass et al., 1994) (Fig. 1),performed on embryo and ovary extracts prepared as described in
indicating that all peroxidasin positive cells originate fromSambrook et al. (1988).
glide/gcm positive cells. We have also used another markerAntibody labeling on embryos was performed as in Vincent et
al. (1996). Double-labeling with 1:1000 rabbit anti-bgal (Cappel) speci®c to the hemocyte/macrophage lineage, the anti-cro-
and 1:100 mouse-anti-peroxidasin (gift of L. Fessler) was detected quemort antibody. croquemort codes for a macrophage re-
using FITC-conjugated goat anti-rabbit and Cy3-conjugated goat ceptor that starts being expressed in peroxidasin positive
anti-mouse. Double-labeling with 1:500 rabbit anti-croquemort cells at late stage 11, when the ®rst phase of apoptosis takes
(gift of J. L. Dimarcq and J. Hoffmann) and 1:2000 mouse anti-bgal place (Franc et al., 1996). As with peroxidasin, croquemort,
(Promega) or with 1:200 rabbit anti-twist (gift of F. Perrin-Schmitt
a membrane-associated molecule, colocalizes with bgal inand B. Thisse) and 1:2000 mouse anti-bgal was detected with FITC-
rA87 embryos (data not shown), indicating that all croquem-conjugated goat anti-mouse and Cy3-conjugated goat anti-rabbit.
ort and peroxidasin positive cells originate from glide/gcmAll secondaries (Jackson) were used at 1:500. Embryos were ob-
positive cells. These results indicate that all glide/gcm posi-served with a conventional (Zeiss axiophot) or confocal (Leica
DMRE) microscope. tive cells become hemocytes.
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FIG. 1. bgal expression in the hemocyte/macrophage lineage. rA87 embryos labeled with anti-bgal (green) and with anti-peroxidasin
(red). (A±D) Ventral views of a stage 13 embryo. (A, B) Peroxidasin labeling showing that hemocytes have completed their migration from
the anterior and from the posterior poles. Note the presence of hemocytes (open arrows) all along the antero±posterior axis. (B±D) Higher
magni®cations of the embryo shown in A. (C) bgal pro®le of expression: hemocytes are indicated by arrows, glial cells in the central
nervous system by open triangles. (D) Double exposure to show colocalization between anti-bgal and anti-peroxidasin (asterisks). (E±G)
Confocal images of an optical section of an early stage 11 embryo, lateral views, labeled with the same antibodies as above. (E) Anti-
peroxidasin labeling; (F) anti-bgal labeling; (G) double exposure. Note in G that peroxidasin, a secreted molecule, and bgal, localized in
the nucleus, are expressed in the same cells (asterisks). Arrowheads indicate the clypeolabrum; curved arrow indicates the posterior-most
part of the elongated germ band. Bars: (A) 50 mm; (B±D) 25 mm; (E±G) 16 mm.
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FIG. 2. twist and glide/gcm are coexpressed in the procephalic mesoderm. (A±C) Cephalic region of a stage 8±9 rA87 embryo double-
labeled with anti-twist (green) and anti-bgal (red) and analyzed by confocal microscopy. (A and B) Optical sections showing anti-bgal and
anti-twist labeling, respectively. (C) Same optical section as in A and B showing colocalization between anti-bgal and anti-twist (yellow
nuclei). (D and E) Projections of optical sections, lower magni®cations of the same embryo as that shown in A±C. (D) Anti-twist; (E)
double-anti-bgal and anti-twist labeling. Note that bgal-expressing cells constitute a subset of the twist-expressing cells in the head and
form a cluster with sharply de®ned borders (arrowheads). Arrows indicate twist-expressing cells that do not express the bgal. Bars: (A±C)
16 mm; (D, E) 63 mm.
glide/gcm Expression in Wild-Type and in Mutant increases during germ band retraction, due to the appear-
ance of new precursors and to cell division. At stage 15Embryos
some glial cells migrate out of the ventral cord to line the
glide/gcm expression in the hemocyte/macrophage lin- peripheral nerves and form exit and peripheral glia. By this
eage has been con®rmed by in situ hybridization (Fig. 3). stage, glide/gcm expression can barely be detected in longi-
The earliest glide/gcm expression in the hemocyte lineage tudinal glia and exit glia and is not present in peripheral
can be detected in the head region at the end of the blasto- glia (Fig. 3), while bgal is still present due to its high stabil-
derm stage (Fig. 3A). glide/gcm represents thus a very early ity (Jones et al., 1995; Vincent et al., 1996). glide/gcm ex-
marker for the hemocyte/macrophage lineage in the em- pression displays differences in abdominal versus thoracic
bryo. At stage 10, the expression in the procephalic meso- segments (see for example Fig. 3F) which re¯ect differences
derm is still very prominent (Fig. 3B). In addition, one cell in glial cell organization (Udolph et al., 1993; Prokop and
per hemisegment is labeled in the lateral ectoderm. By the Technau, 1994; Halter et al., 1995; Ito et al., 1995). After
position, this cell may correspond to cells of the peripheral stage 11, no signal can be detected in cells migrating out of
nervous system. A second labeled cell is located more medi- the procephalic mesoderm, indicating that glide/gcm tran-
ally, at the position of the longitudinal glioblast. scription ceases in differentiated hemocytes.
By stage 11, glide/gcm expression in the hemocyte lineage Interestingly, Western blots with several anti-glide/gcm
decreases, while its expression in glial cells of the peripheral antibodies detect a product in embryos at the syncytial blas-
and central nervous systems becomes evident (Fig. 3C). The toderm stage and in adult ovaries indicating the presence
of a maternal glide/gcm protein (Fig. 4 and data not shown).number of glide/gcm-expressing cells in the ventral cord
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FIG. 4. Detection of the glide/gcm product. Western blot on Dro-
sophila extracts from 0 to 1 hr (0±1) and overnight (O/N) embryos
as well as from adult ovaries (ov). Differences in signal intensity
re¯ect differences in loading. Protein sizes (kDa) are indicated on
the left; the product detected by glide/gcm antibody is indicated
by an arrowhead.
FIG. 5. glide/gcm expression in excision mutants. In situ hybrid-
ization on wild-type (A) and glide/gcm34 (B) embryos using a glide/
gcm speci®c probe, lateral views, stage 10±11. Labeling in the pro-glide/gcm expression in the hemocyte/macrophage pre-
cephalic mesoderm (asterisk) and in the trunk (arrows indicate glial
sumptive territories is severely affected in glide/gcm26 and precursors and a cell in the peripheral nervous system) is almost
glide/gcm34, two hypomorphic mutations generated by im- undetectable in mutants. Arrowheads indicate the stripes along the
precise excisions, while in glide/gcmN7-4 (Jones et al., 1995; dorso±ventral axis.
Vincent et al., 1996), it is normal (Figs. 3 and 5 and data
not shown). glide/gcm expression in the glial lineage is also
affected in the excision mutants (data not shown). In glide/
markers in glide/gcm embryos. In the excision mutants,gcmN7-4 embryos (Fig. 3), the initial pattern of expression in
peroxidasin-expressing cells are slightly reduced in numberthe glial lineage is similar to that observed in the wild type;
and display an altered distribution: some regions are devoidat late stages, however, it is severely affected in that it de-
of hemocytes; furthermore, hemocytes do not envelope thecays much more rapidly.
intestine, as is found in the wild type (data not shown). In
the strong allele glide/gcmN7-4, one-third of hemocytes are
glide/gcm Is Necessary for Hemocyte/Macrophage absent, a phenotype that has been con®rmed by using the
Differentiation anti-croquemort antibody (Fig. 6). Complementation tests
realized previously indicate that the phenotype observed isWe have assessed the role of glide/gcm in this lineage
by analyzing the pro®le of hemocyte/macrophage speci®c to be ascribed speci®cally to the glide/gcm locus. In addi-
FIG. 3. glide/gcm expression during embryogenesis in wild-type and in glide/gcmN7-4. In situ hybridization on wild-type (A±H) or glide/
gcmN7-4 (I±N) embryos with a glide/gcm speci®c probe, ventral views. (A) Expression is ®rst detected at the late blastoderm stage in the
head region (asterisk). By stage 10 (B), glide/gcm is also expressed in the thoracic and abdominal segments in two cells per hemisegment.
Labeled cells located in the lateral epidermis are indicated by arrowheads, the more medially located cells (arrows) corresponding to the
longitudinal glioblasts. At early stage 12 (C), a metameric expression appears in lateral stripes located along the dorso±ventral axis (thin
arrow). glide/gcm expression in the head decreases, while the number of glide/gcm positive cells in the thoracic and abdominal neuromeres
increases. By this stage, glide/gcm is detected in the longitudinal glioblast, which has divided twice (arrows), and in other glial precursors
(white dots). (D) By mid-stage 12, expression of glide/gcm in the cephalic mesoderm has ceased. In contrast, the number of cells expressing
glide/gcm in the ventral nerve cord has increased again and the medial-most cell body glia (MM-CBG) have moved medially (white arrows).
A peripheral cell expressing glide/gcm is present in each abdominal segment but not in the thorax (p). (E) Late stage 12 embryo. (F) Stage
13 embryo. Most cells have reached their position: longitudinal glial cells start stretching along the antero±posterior axis; the subperineurial
glia and MM-CBG have migrated medially. Note the difference in MM-CBG number between thorax (T) (two pairs) and abdomen (A) (one
pair); see arrows in the detail shown to the right, a higher magni®cation of the region in brackets. (G) Stage 14 embryo: expression decays
in most glial cells. Longitudinal glial cells are now arranged in column along the connectives. Exit and peripheral glia (open arrows) start
migrating to the periphery. (H) Stage 15 embryo: most cells in the ventral cord are not labeled; some glide/gcm-expressing cells are present
in the head region. (I) In mutant embryos at blastoderm stage glide/gcm is expressed as in the wild type. Expression proceeds normally
in stage 10 (J) and until early stage 12 (K). From late stage 12 (L) on, however, fewer cells express glide/gcm compared to the wild type
(see E). Also compare wild-type (G) and mutant (N) stage 14±15 embryos. Bar: 50 mm except in the detail in F (25 mm).
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FIG. 6. Hemocyte phenotype in glide/gcm embryos. Anti-croquemort labeling in wild-type (A, B) and glide/gcmN7-4 (C, D) embryos at
stage 14. A and C show dorsal views, whereas (B) and (D) show a deeper focus plane of the same embryos. (A, B) Macrophages in the head
and along the dorsal epidermis are indicated by arrows. (C, D) In the mutant, fewer macrophages are present in those regions; see asterisks.
Note the strong labeling within the gut (g), most likely due to the yolk. This labeling is observed in both wild-type and mutant embryos.
To estimate the number of missing cells in glide/gcm embryos, croquemort positive cells were counted in three wild-type (295, 317, and
340) and in four mutant (173, 181, 217, and 224) embryos. In both cases, counts were realized on half (right or left) embryos.
tion, Jones et al. (1995) have shown that glide/gcmN7-4 has As for the stripe of ectodermal cells that express glide/
gcm during embryogenesis (see thin arrows in Fig. 3), nothe same phenotype as a mutation that carries a deletion
removing the entire transcript. Therefore, glide/gcmN7-4 is phenotypes have been found in the mutants (data not
shown).likely to be a complete loss of function mutation.
To determine whether the phenotypes observed in the
mutants are due to defects in early steps of hemocyte/mac-
glide/gcm Plays an Instructive Role in therophage differentiation, we have taken advantage of glide/
Hemocyte/Macrophage Lineagegcm34, which carries a partial excision and under heterozy-
gous conditions displays bgal expression as in the original The above results indicate that glide/gcm is expressed and
required in the hemocyte lineage. The mutant phenotyperA87 line (Vincent et al., 1996). The glide/gcm34/glide/
gcmN7-4 combination was analyzed at early stages of embry- suggested that glide/gcm promotes the hemocyte fate; how-
ever, we could not formally exclude that it plays a role inonic development by scoring the bgal positive cells in the
procephalic mesoderm (Fig. 7). Interestingly, the number of hemocyte proliferation. For this reason, we induced ectopic
expression of glide/gcm and asked whether this is suf®cientbgal positive cells is reduced compared to that observed in
rA87 and the intensity of expression is lower. to induce ectopic hemocytes. To this aim, we created a hs-
glide/gcm transgenic line and induced ubiquitous expres-It should be noted that, due to the hypomorphic nature
of the glide/gcm34 allele, glide/gcm is still expressed in this sion during embryonic development. Heat shock on
transgenic embryos leads to a severe increase of anti-peroxi-heteroallelic combination; therefore, the defects are not as
strong as they would be in glide/gcmN7-4 homozygous em- dasin labeling (Figs. 8B±8D), compared to wild-type em-
bryos submitted to the same treatment (Fig. 8A). This indi-bryos. It is interesting to note that the same allelic series
can be established as that observed in glial differentiation, cates that hemocyte differentiation is induced upon glide/
gcm expression.that is, excision alleles display weaker phenotypes com-
pared to glide/gcmN7-4. Ectopic hemocytes are not limited to procephalic meso-
derm territories, suggesting that other cell types may alsoglide/gcm embryos also display defects in migration (Fig.
7 and data not shown). Since glide/gcm is not expressed in have the potential to become hemocytes, provided that
glide/gcm is active. However, since hemocytes are migra-migratory cells (Fig. 3), it is likely that these late defects
are indirect, due to the presence of defective precursors. tory cells, we could not exclude the possibility that, upon
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FIG. 7. Early glide/gcm phenotype in the hemocyte lineage. bgal labeling in rA87// (A±D) and in glide/gcm34/glide/gcmN7-4 (E±I) embryos
at different stages of development. (A and E) Stage 10 embryos, ventral views. Arrows indicate bgal-expressing cells in the procephalic
mesoderm, fewer in the mutant (E) than in the wild type (A). Open triangles show labeling in the lateral epidermis. (B and F) Stage 11±
12 embryos, ventral views. At the beginning of germ band retraction, hemocytes migrate anteriorly throughout the head region, and
posteriorly to the tail end of the germ band, to invade the whole embryo. Note that hemocytes in the mutant (F) are fewer and display
little migration compared to the wild type (B). As already described (Vincent et al., 1996), the number of glial precursors (®lled triangles)
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heat shock, an increased number of cells originating from ping de®ciencies that map in the region containing srp:
Df(3R)sbd105, which eliminates srp, and Df(3R) sbd45, whichthe procephalic mesoderm differentiate into the hemocyte
and subsequently move throughout the embryo. To test does not. In situ hybridization on whole-mount embryos
shows that glide/gcm is not expressed in srp mutants (Fig.more directly the hypothesis that even nonmesodermal
cells are competent to become hemocytes, we created a 9). The effect of srp is limited to the hemocyte lineage,
which indicates that different regulators are required to acti-UAS-glide/gcm transgenic line and crossed it to a driver
that expresses GAL4 in a cell type that is not related to the vate glide/gcm in the hemocyte versus the glial lineage.
mesoderm. Two neural drivers were used for this purpose:
an early one that expresses GAL4 in neuroblasts, the ner-
vous system stem cells, and a late one that expresses GAL4 DISCUSSION
in neurons, the postmitotic differentiated cells. Using the
neuroblast driver we observed that the number of hemo-
glide/gcm Plays Multiple Roles during Embryoniccytes, as assessed by anti-peroxidasin and anti-croquemort
Developmentlabeling, has increased (data not shown). Similar results
were obtained by inducing glide/gcm with the neuronal It is known that hemocytes originate from the head meso-
driver elav-GAL4 (Luo et al., 1994) (Figs. 8E and 8F). It is derm, the formation of which depends on the activity of
interesting to note that cells that become hemocytes are genes such as twist and snail (Simpson, 1983; Nusslein-
located at precise positions. In addition, not all the cells of Volhard et al., 1984) and the homeotic genes (see Bate, 1993,
the ventral cord differentiate into hemocytes. This is in for a review). In this paper we show that glide/gcm is ex-
agreement with the observation that neuronal expression pressed and required in the hemocyte lineage. The results
of glide/gcm also induces glial cell differentiation (Jones et obtained by double-labeling with anti-bgal and hemocyte
al., 1995; Bernardoni et al., unpublished observations). Glial speci®c antibodies and those obtained by in situ hybridiza-
and hemocyte fates are mutually exclusive, since the glial tion indicate that all peroxidasin and croquemort positive
and hemocyte speci®c markers do not colocalize (data not cells originate from glide/gcm positive cells. As in the glial
shown). lineage, glide/gcm expression occurs transiently in the
The fact that ectopic hemocytes express early and late whole hemocyte population. Indeed, its expression, unde-
markers indicates that glide/gcm expression is suf®cient to tectable when hemocytes have differentiated, is almost lim-
promote many aspects of hemocyte differentiation. Indeed, ited to the premigratory cells of the procephalic mesoderm.
transfection of COS cells with a vector expressing croquem- Hemocyte differentiation is affected in glide/gcm mu-
ort enables these cells to bind apoptotic cells, the initial tants. The fact that similar results have been obtained with
event of phagocytosis (Franc et al., 1996). Thus, it is very anti-peroxidasin, expressed from early stages of hemocyte
likely that the croquemort positive cells induced by ectopic differentiation, and anti-croquemort, expressed only when
glide/gcm expression are functional macrophages. The data hemocytes convert into macrophages, indicates that glide/
obtained with cell-speci®c drivers con®rm and extend those gcm is not involved in the hemocyte/macrophage conver-
obtained with the hs-glide/gcm line. sion. Indeed, as in the case of glial cells, glide/gcm muta-
tions affect the hemocyte lineage well before any sign of
differentiation. In the strong mutant, the number of hemo-serpent GATA Factor Regulates glide/gcm in the
cytes and hemocyte precursors is reduced to approximatelyHemocyte Lineage
60% compared to the wild type. The early defects observed
in the mutant strongly suggest that glide/gcm acts by pro-The pro®le of expression of glide/gcm in the hemocyte
lineage is identical to that of serpent (srp) (JuÈ rgens et al., moting hemocyte cell fate. This is also in agreement with
the observation that, in terms of hemocyte number, the1984; Sam et al., 1996), a gene coding for a GATA transcrip-
tion factor also called ABF (Abel et al., 1993). In addition, phenotype observed at late stages is not stronger than that
observed at early stages. Finally, we have shown that ec-it has recently been shown that lack of serpent leads to lack
of hemocytes (Rehorn et al., 1996; Sam et al., 1996). To topic glide/gcm expression is suf®cient to induce hemocyte
differentiation in cells which normally take other cell fates.understand the epistatic relationship between these two
genes, we have analyzed the glide/gcm pro®le of expression We can exclude that an altered pattern of programmed
cell death due to the mutant phenotype or to ectopic glide/in srp embryos. To this purpose, we have used two overlap-
is severely reduced in the mutant. (C and G) Stage 12 embryos, lateral views: the defects observed at earlier stages persist. In particular,
note in G the defective migration toward the clypeolabrum and toward the tail end of the germ band (asterisks) compared to C. (D and
H) Same embryos as in C and G, different focus plane. The number of cells migrating posteriorly and ventrally as well as the extent of
migration are reduced in H compared to D. (I) Stage 13 mutant embryo, ventral view. Migration from both ends of the embryo toward
the middle regions is not complete (compare with Fig. 1A). The region of the embryo devoid of hemocytes is indicated by arrowheads. cl,
clypeolabrum.
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FIG. 8. Ectopic expression of glide/gcm induces hemocyte differentiation. (A) w1118 and (B±D) hs-glide/gcm// embryos labeled with anti-
peroxidasin at 7±9 hr after egg laying. Wild-type and transgenic embryos were submitted to a single 75-min heat shock at 337C at 0±2
hr after egg laying. (A±C) Lateral views. Compared to the embryo in A, ectopic hemocytes (open arrows) are found throughout the
transgenic embryo at ventral positions (B) as well as at lateral and dorsal positions (C). (D) Dorsal view of a transgenic embryo displaying
an extreme phenotype. Note the large ectopic clusters of peroxidasin positive cells in the dorsal region. (E, F) Projections of optical sections
taken through the ventral cord of a wild-type embryo (E) or that of an embryo expressing glide/gcm in neurons (F) using the elav promoter
(elav-GAL4//; UAS-glide/gcm//). Note the increased number of peroxidasin positive cells in the ventral cord of F compared to that
shown in E. Bars: (A±D) 50 mm; (E, F) 45 mm.
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neuronal cells of monocytic origin that morphologically
resemble glial cells (see Perry, 1996, for a review). Mono-
cyte-derived macrophages enter the central nervous system
during development at the time of naturally occurring cell
death. These cells, which differentiate from rounded forms
into microglia with complex morphology, behave as oppor-
tunistic phagocytes that recognize changes on the surface
of a nearby cell undergoing apoptosis. The fact that glide/
gcm plays a role in glial cells and in hemocytes suggests
that common mechanisms of development are required in
the two lineages. It also suggests that these two cell types
were initially functionally linked and that during evolution
their relative roles have become more specialized. This
would also be in agreement with the ®nding that, during
metamorphosis, a period during which the embryonic ner-
vous system is reshaped and many neurons undergo pro-
grammed cell death (see Truman et al., 1993, for a review),
glial cells seem to play the role that hemocytes play in the
embryo. Indeed, it has been shown that glial cells phagocy-
tose neuronal debris in the central nervous system (Cantera
and Technau, 1996). It will be interesting to determine
whether glide/gcm homologs are involved in the same de-
velopmental processes and, if so, whether the same gene is
required for both lineages or whether different genes have
evolved from a common ancestor.
FIG. 9. serpent regulates glide/gcm expression in the hemocyte During normal embryonic development, hemocytes and
lineage. In situ hybridization on whole-mount embryos using a glial cells arise at different stages. Accordingly, glide/gcm
glide/gcm speci®c probe. (A) Wild type and (B) srp embryos, lateral displays a biphasic expression, ®rst in the procephalic meso-
views at stage 9. Arrows show labeling in the procephalic mesoderm; derm and subsequently in glial precursors. Therefore, one
arrowheads indicate labeling in the trunk; asterisk shows the lack possible explanation for glide/gcm being able to induce two
of labeling in the mutant procephalic mesoderm. Bar: 40 mm. distinct cell fates would be that glide/gcm must be tempo-
rally regulated in order to give rise ®rst to hemocytes and
subsequently to glial cells. However, induction of glide/
gcm expression may account for the decrease or for the gcm expression in postmitotic cells of the nervous system
increase in hemocyte number. Indeed, although macro- leads to the differentiation of both hemocytes (this paper)
phages are known to engulf apoptotic cells, cell death and and glial cells (Jones et al., 1995; Bernardoni and Gian-
macrophage development do not depend on each other (Tep- grande, unpublished results). The results obtained with
ass et al., 1994). These data clearly indicate that the effects such a late ectopic expression clearly demonstrate that the
seen on the hemocyte lineage in the mutant and in animals time at which glide/gcm is expressed is not suf®cient to
expressing glide/gcm ectopically are a direct consequence make a choice between the two fates. Interestingly, we have
of altered glide/gcm expression. Therefore, as shown for found that glial and hemocyte fates are mutually exclusive
glial cells (Jones et al., 1995; Hosoya et al., 1995), glide/gcm in that cells expressing glide/gcm ectopically become either
seems to act as a master gene in the hemocyte/macrophage glial or hemocyte cells (data not shown). In the future, it
lineage. will be important to determine how ectopic glide/gcm ex-
It is interesting to note that while glide/gcm is necessary pression in a single cell type such as the neuron results in
and suf®cient for the differentiation of all glial cells, its
the activation of different and mutually exclusive cell fates.
mutation only eliminates some of the embryonic hemo-
Finally, it is interesting to note that serpent speci®callycytes. A partial loss of hemocytes may have at least two
affects glide/gcm expression in the hemocyte lineage.explanations. First, the observation that a glide/gcm prod-
Whether other GATA transcription factors affect its expres-uct is detected in preblastoderm embryos and in adult ova-
sion in the glial lineage awaits further analyses.ries suggests the presence of a maternal component. Second,
hemocytes may require more than one gene in order to
differentiate. In this respect, it is worth noting that a second The glide/gcm Locus
gene carrying the glide/gcm binding motif has been found
glide/gcm codes for a protein with DNA binding proper-in Drosophila (Akiyama et al., 1996).
ties (Akiyama et al., 1996). The most likely role of this
Glial and Scavenger Cells protein is to regulate the expression of downstream genes
that execute a speci®c cell differentiation program. In vivoIn the vertebrate central nervous system the role of scav-
enger cells is played by microglia, a population of non- and in vitro analyses have identi®ed genes that are regulated
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supported by funds from the Institut National de la SanteÂ et de laby glide/gcm and that execute the glial differentiation pro-
Recherche MeÂdicale, the Centre National de la Recherche Scienti-gram (Hosoya et al., 1995; Jones et al., 1995; Vincent et
®que, the Centre Hospitalier Universitaire ReÂgionale, and the Asso-al., 1996; Akiyama et al., 1996). As shown by the epistasy
ciation pour la Recherche contre le Cancer.between serpent and glide/gcm, our ®ndings will make it
possible to start identifying other genes required during he-
mocyte development.
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